Endovascular stroke trials and treatment time
| Study | Time to groin (median) (min) | Time to reperfusion (median) (min) | mRS 0–2 Endovascular (%) | mRS 0–2 Medical (%) | Absolute difference (%) |
|---|---|---|---|---|---|
| IMS III | 208 | 325 | 40.8 | 38.7 | 2.1 |
| MR CLEAN | 260 | 332 | 32.6 | 19.1 | 13.5 |
| REVASCAT | 269 | 355 | 43.7 | 28.2 | 15.5 |
| SWIFT PRIME | 224 | 252 | 60.2 | 35.5 | 24.7 |
| EXTEND IA | 210 | 248 | 71 | 40 | 31 |
| ESCAPE | 185 | 241 | 53 | 29.3 | 23.7 |
IMS, Interventional Management of Stroke; mRS, modified Rankin Scale.